Search Results - "FARACI, W. S"

Refine Results
  1. 1

    2‐Amino‐4‐methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo by Faraci, W. Stephen, Nagel, Arthur A., Verdries, Kimberly A., Vincent, Lawrence A., Xu, Hong, Nichols, Lois E., Labasi, Jeffrey M., Salter, Eben D., Pettipher, E. Roy

    Published in British journal of pharmacology (01-11-1996)
    “…1 The ability of 2‐amino‐4‐methylpyridine to inhibit the catalytic activity of the inducible NO synthase (NOS II) enzyme was characterized in vitro and in…”
    Get full text
    Journal Article
  2. 2

    Posttranslational Amino Acid Epimerization: Enzyme-Catalyzed Isomerization of Amino Acid Residues in Peptide Chains by Heck, Steven D., Faraci, W. Stephen, Kelbaugh, Paul R., Saccomano, Nicholas A., Thadeio, Peter F., Volkmann, Robert A.

    “…Since ribosomally mediated protein biosynthesis is confined to the L-amino acid pool, the presence of D-amino acids in peptides was considered for many years…”
    Get full text
    Journal Article
  3. 3

    Slow tight-binding inhibition of prolyl endopeptidase by benzyloxycarbonyl-prolyl-prolinal by Bakker, A V, Jung, S, Spencer, R W, Vinick, F J, Faraci, W S

    Published in Biochemical journal (15-10-1990)
    “…Prolyl endopeptidase is a serine proteinase that specifically cleaves peptides on the carboxy side of proline residues. Wilk & Orlowski [(1983) J. Neurochem…”
    Get full text
    Journal Article
  4. 4

    Subcloning, expression, and purification of the enterobactin biosynthetic enzyme 2,3-dihydroxybenzoate-AMP ligase: demonstration of enzyme-bound (2,3-dihydroxybenzoyl)adenylate product by Rusnak, Frank, Faraci, W. Stephen, Walsh, Christopher T

    Published in Biochemistry (Easton) (22-08-1989)
    “…The gene coding for the enzyme 2,3-dihydroxybenzoate-AMP ligase (2,3DHB-AMP ligase), responsible for activating 2,3-dihydroxybenzoic acid in the biosynthesis…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Beryllium competitively inhibits brain myo-inositol monophosphatase, but unlike lithium does not enhance agonist-induced inositol phosphate accumulation by FARACI, W. S, ZORN, S. H, BAKKER, A. V, JACKSON, E, PRATT, K

    Published in Biochemical journal (15-04-1993)
    “…Despite limiting side-effects, lithium is the drug of choice for the treatment of bipolar depression. Its action may be due, in part, to its ability to dampen…”
    Get full text
    Journal Article
  8. 8

    Mechanism of inhibition of the PC1 .beta.-lactamase of Staphylococcus aureus by cephalosporins: importance of the 3'-leaving group by Faraci, W. Stephen, Pratt, Rex F

    Published in Biochemistry (Easton) (01-02-1985)
    “…The hydrolysis of cephalosporins containing good leaving groups at the 3'-position [those used in this study were the chromogenic cephalosporin PADAC…”
    Get full text
    Journal Article
  9. 9

    Mechanism of inhibition of RTEM-2β-lactamase by cephamycins: relative importance of the 7α-methoxy group and the 3' leaving group by FARACI, W. S, PRATT, R. F

    Published in Biochemistry (Easton) (20-05-1986)
    “…Cefoxitin is a poor substrate of many beta-lactamases, including the RTEM-2 enzyme. Fisher and co-workers [Fisher, J., Belasco, J. G., Khosla, S., & Knowles,…”
    Get full text
    Journal Article
  10. 10

    Interactions of cephalosporins with the Streptomyces R61 DD-transpeptidase/carboxypeptidase. Influence of the 3'-substituent by Faraci, W S, Pratt, R F

    Published in Biochemical journal (15-08-1986)
    “…The influence and fate of the 3'-substituent of a series of cephalosporins on their interaction with the DD-transpeptidase/carboxypeptidase of Streptomyces R61…”
    Get full text
    Journal Article
  11. 11

    Novel inhibitors of prolyl endopeptidase: effects of stereochemistry by Kolosko, N, Bakker, A V, Faraci, W S, Nagel, A A

    Published in Drug design and discovery (01-01-1994)
    “…Prolyl endopeptidase is a serine protease that specifically cleaves peptides on the carboxyl side of proline residues. We have show that racemic…”
    Get more information
    Journal Article
  12. 12

    Synthesis, sar and pharmacology of CP-293,019 : A potent, selective dopamine D4 receptor antagonist by SANNER, M. A, CHAPPIE, T. A, MAJCHRZAK, M. J, FARACI, W. S, COLLINS, J. L, DUIGNAN, D. B, DI PRETE, C. C, LEE, J. S, TROZZI, A, DUNAISKIS, A. R, FLIRI, A. F, DESAI, K. A, ZORN, S. H, JACKSON, E. R, JOHNSON, C. G, MORRONE, J. M, SEYMOUR, P. A

    Published in Bioorganic & medicinal chemistry letters (07-04-1998)
    “…A series of novel, potent and selective pyrido[1,2-a]pyrazine dopamine D4 receptor antagonists are reported including CP-293,019 (D4 Ki = 3.4 nM, D2 Ki > 3,310…”
    Get full text
    Journal Article
  13. 13

    Inhibition of Helicobacter pylori Urease by Phenyl Phosphorodiamidates: Mechanism of Action by Faraci, W.Stephen, Yang, Bingwei V., O'Rourke, Dawn, Spencer, Robin W.

    Published in Bioorganic & medicinal chemistry (01-05-1995)
    “…Helicobacter pylori urease is a nickel-containing enzyme that hydrolyzes urea to bicarbonate and ammonia. Andrews et al. ( J. Am. Chem. Soc. 1986, 108, 7124) 1…”
    Get full text
    Journal Article
  14. 14

    The discovery of potent and selective dopamine D4 receptor antagonists by Faraci, W Stephen, Zorn, Stevin H, Sanner, Mark A, Fliri, Anton

    Published in Current opinion in chemical biology (01-08-1998)
    “…The identification of a novel dopamine receptor subtype, referred to as the D4 receptor, which binds the atypical antipsychoti drug clozapine with high…”
    Get full text
    Journal Article
  15. 15

    Mechanism of inactivation of alanine racemase by .beta.,.beta.,.beta.-trifluoroalanine by Faraci, W. Stephen, Walsh, Christopher T

    Published in Biochemistry (Easton) (24-01-1989)
    “…The alanine racemases are a group of PLP-dependent bacterial enzymes that catalyze the racemization of alanine, providing D-alanine for cell wall synthesis…”
    Get full text
    Journal Article
  16. 16

    Nucleophilic re-activation of the PC1 beta-lactamase of Staphylococcus aureus and of the DD-peptidase of Streptomyces R61 after their inactivation by cephalosporins and cephamycins by Faraci, W S, Pratt, R F

    Published in Biochemical journal (15-09-1987)
    “…It has been shown previously [Faraci & Pratt (1985) Biochemistry 24, 903-910; (1986) Biochemistry 25, 2934-2941; (1986) Biochem. J. 238, 309-312] that certain…”
    Get full text
    Journal Article
  17. 17

    Racemization of alanine by the alanine racemases from Salmonella typhimurium and Bacillus stearothermophilus: energetic reaction profiles by Faraci, W. Stephen, Walsh, Christopher T

    Published in Biochemistry (Easton) (03-05-1988)
    “…Alanine racemases are bacterial pyridoxal 5'-phosphate (PLP) dependent enzymes providing D-alanine as an essential building block for biosynthesis of the…”
    Get full text
    Journal Article
  18. 18

    (1-Aminoethyl)boronic acid: a novel inhibitor for Bacillus stearothermophilus alanine racemase and Salmonella typhimurium D-alanine:D-alanine ligase (ADP-forming) by Duncan, Kenneth, Faraci, W. Stephen, Matteson, Donald S, Walsh, Christopher T

    Published in Biochemistry (Easton) (18-04-1989)
    “…(1-Aminoethyl)boronic acid (Ala-B), an analogue of alanine in which a boronic acid group replaces the carboxyl group, has been synthesized and found to inhibit…”
    Get full text
    Journal Article
  19. 19

    Inhibition of alanine racemase by alanine phosphonate: detection of an imine linkage to pyridoxal 5'-phosphate in the enzyme-inhibitor complex by solid-state 15N nuclear magnetic resonance by COPIE, V, FARACI, W. S, WALSH, C. T, GRIFFIN, R. G

    Published in Biochemistry (Easton) (12-07-1988)
    “…Inhibition of alanine racemase from the Gram-positive bacterium Bacillus stearothermophilus by (1-aminoethyl) phosphonic acid (Ala-P) proceeds via a two-step…”
    Get full text
    Journal Article
  20. 20

    Phosphodiesterases in the CNS: targets for drug development by Schmidt, Christopher J, Menniti, Frank S, Faraci, W. Stephen

    Published in Nature reviews. Drug discovery (01-08-2006)
    “…The therapeutic and commercial success of phosphodiesterase 5 inhibitors such as Viagra, Levitra and Cialis has sparked renewed interest in the…”
    Get full text
    Journal Article